Holen Sie sich die Stockscreener-App
0.1065
0.00%
0.00
Handel nachbörslich:
.10
-0.0065
-6.10%
Finanzdaten der Quince Therapeutics Inc-Aktie (QNCX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
28.80%
13.43
|
10.43 | 14.86 | 12.01 | 5.863 |
| Depreciation and Amortization |
2.86%
0.036
|
0.035 | 0.032 | 0.016 | 0.086 |
| Operating Income/Loss |
28.80%
-13.43
|
-10.43 | -14.86 | -12.01 | -5.863 |
| Income/Loss From Continuing Operations Before Tax |
14.96%
-13.53
|
-15.91 | -14.98 | -12.45 | -5.466 |
| Income Tax Expense/Benefit |
168.66%
-0.046
|
0.067 | 0.047 | 0.007 | 0.013 |
| Income/Loss From Continuing Operations After Tax |
15.61%
-13.49
|
-15.98 | -15.03 | -12.46 | -5.479 |
|
Net Income/Loss
|
15.61%
-13.49
|
-15.98 | -15.03 | -12.46 | -5.479 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
168.66%
-0.046
|
0.067 | - | - | 0.013 |
| Basic Average Shares |
15.56%
53.95
|
46.69 | 43.94 | 0.1716 | 43.16 |
| Diluted Average Shares |
15.56%
53.95
|
46.69 | 43.94 | 0.1716 | 43.16 |
| Basic Earnings Per Share |
26.47%
-0.25
|
-0.34 | -0.34 | -0.28 | -0.13 |
| Diluted Earnings Per Share |
26.47%
-0.25
|
-0.34 | -0.34 | -0.28 | -0.13 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):